WallStreetZenWallStreetZen

NASDAQ: TLIS
Talis Biomedical Corp Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for TLIS

Based on 2 analysts offering 12 month price targets for Talis Biomedical Corp.
Min Forecast
$1.00+38.5%
Avg Forecast
$1.25+73.13%
Max Forecast
$1.50+107.76%

Should I buy or sell TLIS stock?

Based on 2 analysts offering ratings for Talis Biomedical Corp.
Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
1 analysts 50%
Strong Sell
1 analysts 50%

Be the first to know when Wall Street analysts revise their TLIS stock forecasts and price targets.

TLIS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BTIG
Top 31%
70
Strong SellDowngrades$1.00+38.50%2022-03-18
Bank of America
Top 6%
95
SellMaintains$1.50+107.76%2022-03-16

1 of 1

Forecast return on equity

Is TLIS forecast to generate an efficient return?
Company
-69.24%
Industry
19.47%
Market
110.54%
TLIS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TLIS forecast to generate an efficient return on assets?
Company
-55.29%
Industry
10.83%
TLIS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TLIS earnings per share forecast

What is TLIS's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$3.88
Avg 2 year Forecast
-$2.60
Avg 3 year Forecast
-$2.17

TLIS revenue forecast

What is TLIS's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.5M-7.76%
Avg 2 year Forecast
$1.0M-79.32%
Avg 3 year Forecast
$18.7M+287.59%
TLIS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TLIS revenue growth forecast

How is TLIS forecast to perform vs Medical Devices companies and vs the US market?
Company
29.17%
Industry
4.64%
Market
8.49%
TLIS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TLIS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TLIS vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
TLIS$0.72$1.25+73.13%Strong Sell
EAR$1.04$10.00+861.54%Sell
IRIX$2.50$3.00+20.00%Hold
CFMS$0.20$2.00+890.10%Buy
MODD$3.40$9.50+179.41%Strong Buy

Talis Biomedical Stock Forecast FAQ

Is Talis Biomedical Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TLIS) stock is to Strong Sell TLIS stock.

Out of 2 analysts, 0 (0%) are recommending TLIS as a Strong Buy, 0 (0%) are recommending TLIS as a Buy, 0 (0%) are recommending TLIS as a Hold, 1 (50%) are recommending TLIS as a Sell, and 1 (50%) are recommending TLIS as a Strong Sell.

If you're new to stock investing, here's how to buy Talis Biomedical stock.

What is TLIS's earnings growth forecast for 2022-2024?

(NASDAQ: TLIS) Talis Biomedical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 26.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.09%.

Talis Biomedical's earnings in 2022 is -$127,134,000.On average, 2 Wall Street analysts forecast TLIS's earnings for 2022 to be -$219,153,629, with the lowest TLIS earnings forecast at -$229,320,550, and the highest TLIS earnings forecast at -$208,986,708. On average, 2 Wall Street analysts forecast TLIS's earnings for 2023 to be -$146,855,524, with the lowest TLIS earnings forecast at -$157,022,445, and the highest TLIS earnings forecast at -$136,123,775.

In 2024, TLIS is forecast to generate -$122,567,880 in earnings, with the lowest earnings forecast at -$122,567,880 and the highest earnings forecast at -$122,567,880.

What is TLIS's revenue growth forecast for 2022-2024?

(NASDAQ: TLIS) Talis Biomedical's forecast annual revenue growth rate of 29.17% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4.64%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.49%.

Talis Biomedical's revenue in 2022 is $4,835,000.On average, 1 Wall Street analysts forecast TLIS's revenue for 2022 to be $251,913,707, with the lowest TLIS revenue forecast at $251,913,707, and the highest TLIS revenue forecast at $251,913,707. On average, 1 Wall Street analysts forecast TLIS's revenue for 2023 to be $56,482,894, with the lowest TLIS revenue forecast at $56,482,894, and the highest TLIS revenue forecast at $56,482,894.

In 2024, TLIS is forecast to generate $1,058,489,434 in revenue, with the lowest revenue forecast at $1,058,489,434 and the highest revenue forecast at $1,058,489,434.

What is TLIS's forecast return on assets (ROA) for 2022-2024?

(NASDAQ: TLIS) forecast ROA is -55.29%, which is lower than the forecast US Medical Devices industry average of 10.83%.

What is TLIS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TLIS price target, the average TLIS price target is $1.25, with the highest TLIS stock price forecast at $1.50 and the lowest TLIS stock price forecast at $1.00.

On average, Wall Street analysts predict that Talis Biomedical's share price could reach $1.25 by Mar 18, 2023. The average Talis Biomedical stock price prediction forecasts a potential upside of 73.13% from the current TLIS share price of $0.72.

What is TLIS's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: TLIS) Talis Biomedical's current Earnings Per Share (EPS) is -$3.82. On average, analysts forecast that TLIS's EPS will be -$3.88 for 2022, with the lowest EPS forecast at -$4.06, and the highest EPS forecast at -$3.70. On average, analysts forecast that TLIS's EPS will be -$2.60 for 2023, with the lowest EPS forecast at -$2.78, and the highest EPS forecast at -$2.41. In 2024, TLIS's EPS is forecast to hit -$2.17 (min: -$2.17, max: -$2.17).

What is TLIS's forecast return on equity (ROE) for 2022-2024?

(NASDAQ: TLIS) forecast ROE is -69.24%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.